Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma.
Journal Information
Full Title: Cancer Cell Int
Abbreviation: Cancer Cell Int
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateThe First Affiliated Hospital of Zhengzhou University’s Ethics Committee approved this study in accordance with the Declaration of Helsinki (Approval Number: 2019-KY-176). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding Henan Natural Science Fund Project, China [grant number 212300410401] funded this research."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025